His coverage has had a profound impact on the field of oncology, leading to numerous Congressional investigations, and helped change policy, regulation, and standards of care.
Paul’s reporting has been recognized by the Washington DC Professional Chapter of the Society of Professional Journalists, the Gerald Loeb Awards, the Association of Health Care Journalists, and the Newsletter and Electronic Publishers Foundation.
His articles have appeared in The New York Times, The Wall Street Journal, The Washington Post and The Washington Monthly, and he has been featured on 60 Minutes, 20/20, CNN and NPR. He is also a novelist and author of nonfiction books.
His author website is www.paulgoldberg.com.
Paul graduated from Duke University with a B.A. in economics in 1981.
Books
The Yid
(Picador, Macmillan Publishers, 2016)
How We Do Harm: A Doctor Break Ranks About Being Sick in America
with Otis W. Brawley, (St. Martin’s Press, 2012)
The Thaw Generation: Coming of Age in the Post-Stalin Era
(Little, Brown, 1990; and in paperback, University of Pittsburgh Press) with Ludmilla Alexeyeva

To Live Like Everyone
translation of a memoir of Anatoly Marchenko (Henry Holt, 1989)

The Final Act
(William Morrow, 1988)
Latest Stories
NCI will immediately start the process of streamlining IND-exempt trials in order to make them faster, simpler, more flexible, less expensive, and easier to integrate with clinical practice, James Doroshow, NCI deputy director for clinical and translational research and director of the Division of Cancer Treatment and Diagnosis, said to The Cancer Letter. On Nov....
Patient navigation didn’t start out as a business idea. The concept—and the adaptation of the nautical term—are attributed to the surgeon Harold Freeman, when he started to practice in Harlem after finishing his residency at Memorial Sloan Kettering Cancer Center in 1968. “If people meet barriers in getting through the healthcare system with cancer and...
Companies vying for accelerated approval and devising strategies for confirmatory trials would be best served by seeking prospective sign-off from FDA, agency officials say. Officials from the FDA Oncology Center of Excellence described these best practices in a perspective piece in the Sept. 21 issue of The New England Journal of Medicine and discussed the...
Some things are known to grow well in Kansas. Some things aren’t. Over the past 18 years, Roy Jensen has been told time and again that it made no sense to even try to grow an NCI-designated Comprehensive Cancer Center in Kansas. Yet, he did the only thing he could. Persist. Stubbornly. The University of...
In a 14:1 vote, ODAC nixes a PD-1 drug developed in China; data not generalizable to U.S. population
On Dec. 8, 2020, a month after losing the election, then-president Donald Trump announced his intent to name 26 people to advisory boards across the federal government. Among them were three would-be members of the National Cancer Advisory Board, and in the months following, these three appointments—which have been blocked and ultimately terminated by the...
John A. Ellerton, the principal investigator of the Nevada Cancer Research Foundation NCI Community Oncology Research Program, has won the 2021 Harry Hynes Award. The award is given annually to NCORP PIs for outstanding contribution to clinical trials and community research. In 1983, Ellerton’s group, then called the Southern Nevada Research Foundation, was among the...